Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Prostate Cancer

Open Label Study of Sipuleucel-T
An Open Label Study of Sipuleucel-T in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/5/2015
Virginia Mason Medical Center Urology and Renal Transplantation
mi
from
Seattle, WA
Open Label Study of Sipuleucel-T
An Open Label Study of Sipuleucel-T in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/5/2015
Virginia Mason Medical Center Urology and Renal Transplantation
mi
from
Seattle, WA
Click here to add this to my saved trials
Open Label Study of Sipuleucel-T
An Open Label Study of Sipuleucel-T in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated:  10/5/2015
Aurora Advanced Healthcare, Inc.
mi
from
Wauwatosa, WI
Open Label Study of Sipuleucel-T
An Open Label Study of Sipuleucel-T in Men With Metastatic Castrate Resistant Prostate Cancer
Status: Enrolling
Updated: 10/5/2015
Aurora Advanced Healthcare, Inc.
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Brief Physician-Initiated Quit Smoking Strategies for Clinical Oncology Settings
Status: Enrolling
Updated:  10/6/2015
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Brief Physician-Initiated Quit Smoking Strategies for Clinical Oncology Settings
Status: Enrolling
Updated: 10/6/2015
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated:  10/7/2015
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated: 10/7/2015
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated:  10/7/2015
Investigational Drug Service
mi
from
Atlanta, GA
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated: 10/7/2015
Investigational Drug Service
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated:  10/7/2015
The Emory Clinic
mi
from
Atlanta, GA
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated: 10/7/2015
The Emory Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated:  10/7/2015
Loyola University Medical Center
mi
from
Maywood, IL
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated: 10/7/2015
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated:  10/7/2015
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated: 10/7/2015
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated:  10/7/2015
Siteman Cancer Center-West County
mi
from
Creve Couer, MO
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated: 10/7/2015
Siteman Cancer Center-West County
mi
from
Creve Couer, MO
Click here to add this to my saved trials
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated:  10/7/2015
Barnes Jewish Hospital
mi
from
St. Louis, MO
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated: 10/7/2015
Barnes Jewish Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated:  10/7/2015
Washington University School of Medicine, Siteman Cancer Center
mi
from
St. Louis, MO
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated: 10/7/2015
Washington University School of Medicine, Siteman Cancer Center
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated:  10/7/2015
Siteman Cancer Center
mi
from
St. Peters, MO
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated: 10/7/2015
Siteman Cancer Center
mi
from
St. Peters, MO
Click here to add this to my saved trials
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated:  10/7/2015
Comprehensive Cancer Center of Nevada
mi
from
Las Vegas, NV
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated: 10/7/2015
Comprehensive Cancer Center of Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated:  10/7/2015
Comprehensive Cancer Centers of Nevada
mi
from
Las Vegas, NV
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated: 10/7/2015
Comprehensive Cancer Centers of Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated:  10/7/2015
Northwest Cancer Specialists, Pc
mi
from
Portland, OR
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated: 10/7/2015
Northwest Cancer Specialists, Pc
mi
from
Portland, OR
Click here to add this to my saved trials
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated:  10/7/2015
US Oncology Research and Clinical Pharmacy (Drug Shipment Only)
mi
from
Fort Worth, TX
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated: 10/7/2015
US Oncology Research and Clinical Pharmacy (Drug Shipment Only)
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated:  10/7/2015
US Oncology Research and Clinical Pharmacy (Drug Shipment Only)
mi
from
Fortworth, TX
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated: 10/7/2015
US Oncology Research and Clinical Pharmacy (Drug Shipment Only)
mi
from
Fortworth, TX
Click here to add this to my saved trials
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated:  10/7/2015
The Strelitz Diabetes Institute of Eastern Virginia Medical School
mi
from
Norfolk, VA
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated: 10/7/2015
The Strelitz Diabetes Institute of Eastern Virginia Medical School
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated:  10/7/2015
Clinica Viedma
mi
from
Viedma,
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.
An Open-label Sunitinib Malate (su011248) Continuation Protocol For Patients Who Have Completed A Prior Sunitinib Study And Are Judged By The Investigator To Have The Potential To Benefit From Sunitinib Treatment
Status: Enrolling
Updated: 10/7/2015
Clinica Viedma
mi
from
Viedma,
Click here to add this to my saved trials
Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
Phase II Open Label, Multi-Center Clinical Trial Of Modulation Of Intermediate Endpoint Biomarkers By 1x-Hydroxyvitamin D2 In Patients With Clinically Localized Prostate Cancer And High Grade PIN
Status: Enrolling
Updated:  10/9/2015
Holden Comprehensive Cancer Center at University of Iowa
mi
from
Iowa City, IA
Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
Phase II Open Label, Multi-Center Clinical Trial Of Modulation Of Intermediate Endpoint Biomarkers By 1x-Hydroxyvitamin D2 In Patients With Clinically Localized Prostate Cancer And High Grade PIN
Status: Enrolling
Updated: 10/9/2015
Holden Comprehensive Cancer Center at University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
Phase II Open Label, Multi-Center Clinical Trial Of Modulation Of Intermediate Endpoint Biomarkers By 1x-Hydroxyvitamin D2 In Patients With Clinically Localized Prostate Cancer And High Grade PIN
Status: Enrolling
Updated:  10/9/2015
James P. Wilmot Cancer Center at University of Rochester Medical Center
mi
from
Rochester, NY
Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
Phase II Open Label, Multi-Center Clinical Trial Of Modulation Of Intermediate Endpoint Biomarkers By 1x-Hydroxyvitamin D2 In Patients With Clinically Localized Prostate Cancer And High Grade PIN
Status: Enrolling
Updated: 10/9/2015
James P. Wilmot Cancer Center at University of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
Phase II Open Label, Multi-Center Clinical Trial Of Modulation Of Intermediate Endpoint Biomarkers By 1x-Hydroxyvitamin D2 In Patients With Clinically Localized Prostate Cancer And High Grade PIN
Status: Enrolling
Updated:  10/9/2015
Veterans Affairs Medical Center - Madison
mi
from
Madison, WI
Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
Phase II Open Label, Multi-Center Clinical Trial Of Modulation Of Intermediate Endpoint Biomarkers By 1x-Hydroxyvitamin D2 In Patients With Clinically Localized Prostate Cancer And High Grade PIN
Status: Enrolling
Updated: 10/9/2015
Veterans Affairs Medical Center - Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
Phase II Open Label, Multi-Center Clinical Trial Of Modulation Of Intermediate Endpoint Biomarkers By 1x-Hydroxyvitamin D2 In Patients With Clinically Localized Prostate Cancer And High Grade PIN
Status: Enrolling
Updated:  10/9/2015
Meriter Hospital, Inc.
mi
from
Madison, WI
Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
Phase II Open Label, Multi-Center Clinical Trial Of Modulation Of Intermediate Endpoint Biomarkers By 1x-Hydroxyvitamin D2 In Patients With Clinically Localized Prostate Cancer And High Grade PIN
Status: Enrolling
Updated: 10/9/2015
Meriter Hospital, Inc.
mi
from
Madison, WI
Click here to add this to my saved trials
Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
Phase II Open Label, Multi-Center Clinical Trial Of Modulation Of Intermediate Endpoint Biomarkers By 1x-Hydroxyvitamin D2 In Patients With Clinically Localized Prostate Cancer And High Grade PIN
Status: Enrolling
Updated:  10/9/2015
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
Phase II Open Label, Multi-Center Clinical Trial Of Modulation Of Intermediate Endpoint Biomarkers By 1x-Hydroxyvitamin D2 In Patients With Clinically Localized Prostate Cancer And High Grade PIN
Status: Enrolling
Updated: 10/9/2015
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
Phase II Open Label, Multi-Center Clinical Trial Of Modulation Of Intermediate Endpoint Biomarkers By 1x-Hydroxyvitamin D2 In Patients With Clinically Localized Prostate Cancer And High Grade PIN
Status: Enrolling
Updated:  10/9/2015
Medical College of Wisconsin Cancer Center
mi
from
Milwaukee, WI
Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
Phase II Open Label, Multi-Center Clinical Trial Of Modulation Of Intermediate Endpoint Biomarkers By 1x-Hydroxyvitamin D2 In Patients With Clinically Localized Prostate Cancer And High Grade PIN
Status: Enrolling
Updated: 10/9/2015
Medical College of Wisconsin Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer
A Pilot Study of 11C-Acetate Positron Emission Tomography (PET) and 3 Telsa Magnetic Resonance Imaging (MRI) in Men With Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated:  10/13/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer
A Pilot Study of 11C-Acetate Positron Emission Tomography (PET) and 3 Telsa Magnetic Resonance Imaging (MRI) in Men With Prostate Cancer Undergoing Prostatectomy
Status: Enrolling
Updated: 10/13/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer
Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer
Status: Enrolling
Updated:  10/13/2015
Queen's Medical Center
mi
from
Honolulu, HI
Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer
Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer
Status: Enrolling
Updated: 10/13/2015
Queen's Medical Center
mi
from
Honolulu, HI
Click here to add this to my saved trials
F-18 Sodium Fluoride in Prostate Cancer
A Pilot Study of F-18 Sodium Fluoride PET/CT for Metastatic Burden Qualification in Prostate Cancer
Status: Enrolling
Updated:  10/13/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
F-18 Sodium Fluoride in Prostate Cancer
A Pilot Study of F-18 Sodium Fluoride PET/CT for Metastatic Burden Qualification in Prostate Cancer
Status: Enrolling
Updated: 10/13/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer
An Open-Label, Phase I, Randomized Pharmacokinetic Study of Dietary Effects on Abiraterone Acetate Drug Levels in Patients With Metastatic Castration-Resistant Prostate Cancer (DEAL)
Status: Enrolling
Updated:  10/13/2015
OHSU Knight Cancer Institute
mi
from
Portland, OR
Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer
An Open-Label, Phase I, Randomized Pharmacokinetic Study of Dietary Effects on Abiraterone Acetate Drug Levels in Patients With Metastatic Castration-Resistant Prostate Cancer (DEAL)
Status: Enrolling
Updated: 10/13/2015
OHSU Knight Cancer Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Prevention of Lymphoceles After Robotic PLND
A Pilot Clinical Trial for the Prevention of Lymphoceles After Robotic Pelvic Lymph Node Dissections for Prostate Malignancies Using the da Vinci® EndoWrist® One™ Vessel Sealer
Status: Enrolling
Updated:  10/13/2015
Dublin Methodist Hospital
mi
from
Columbus, OH
Prevention of Lymphoceles After Robotic PLND
A Pilot Clinical Trial for the Prevention of Lymphoceles After Robotic Pelvic Lymph Node Dissections for Prostate Malignancies Using the da Vinci® EndoWrist® One™ Vessel Sealer
Status: Enrolling
Updated: 10/13/2015
Dublin Methodist Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Positioning and Tracking the Prostate During External Beam Radiation
Beacon® Transponder Implantation and Localization in the Prostate
Status: Enrolling
Updated:  10/13/2015
Scottsdale Healthcare - Osborn
mi
from
Scottsdale, AZ
Positioning and Tracking the Prostate During External Beam Radiation
Beacon® Transponder Implantation and Localization in the Prostate
Status: Enrolling
Updated: 10/13/2015
Scottsdale Healthcare - Osborn
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Positioning and Tracking the Prostate During External Beam Radiation
Beacon® Transponder Implantation and Localization in the Prostate
Status: Enrolling
Updated:  10/13/2015
Sharp Memorial Hospital
mi
from
San Diego, CA
Positioning and Tracking the Prostate During External Beam Radiation
Beacon® Transponder Implantation and Localization in the Prostate
Status: Enrolling
Updated: 10/13/2015
Sharp Memorial Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Positioning and Tracking the Prostate During External Beam Radiation
Beacon® Transponder Implantation and Localization in the Prostate
Status: Enrolling
Updated:  10/13/2015
M.D. Anderson Cancer Center at Orlando
mi
from
Orlando, FL
Positioning and Tracking the Prostate During External Beam Radiation
Beacon® Transponder Implantation and Localization in the Prostate
Status: Enrolling
Updated: 10/13/2015
M.D. Anderson Cancer Center at Orlando
mi
from
Orlando, FL
Click here to add this to my saved trials
Positioning and Tracking the Prostate During External Beam Radiation
Beacon® Transponder Implantation and Localization in the Prostate
Status: Enrolling
Updated:  10/13/2015
Nebraska Medical Center
mi
from
Omaha, NE
Positioning and Tracking the Prostate During External Beam Radiation
Beacon® Transponder Implantation and Localization in the Prostate
Status: Enrolling
Updated: 10/13/2015
Nebraska Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Positioning and Tracking the Prostate During External Beam Radiation
Beacon® Transponder Implantation and Localization in the Prostate
Status: Enrolling
Updated:  10/13/2015
Cleveland Clinic
mi
from
Cleveland, OH
Positioning and Tracking the Prostate During External Beam Radiation
Beacon® Transponder Implantation and Localization in the Prostate
Status: Enrolling
Updated: 10/13/2015
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
CMT-07-08: The PROstate Bed Evaluation Study
The Probe Study - The PROstate Bed Evaluation - A Study to Record the Implant Experience, Transponder Stability and Tracking Data of the Calypso 4D Localization Study in the Prostate Bed
Status: Enrolling
Updated:  10/13/2015
21C Oncology - Scottsdale
mi
from
Scottsdale, AZ
CMT-07-08: The PROstate Bed Evaluation Study
The Probe Study - The PROstate Bed Evaluation - A Study to Record the Implant Experience, Transponder Stability and Tracking Data of the Calypso 4D Localization Study in the Prostate Bed
Status: Enrolling
Updated: 10/13/2015
21C Oncology - Scottsdale
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
CMT-07-08: The PROstate Bed Evaluation Study
The Probe Study - The PROstate Bed Evaluation - A Study to Record the Implant Experience, Transponder Stability and Tracking Data of the Calypso 4D Localization Study in the Prostate Bed
Status: Enrolling
Updated:  10/13/2015
Metropolitan Uro-Rad
mi
from
St. Louis, MO
CMT-07-08: The PROstate Bed Evaluation Study
The Probe Study - The PROstate Bed Evaluation - A Study to Record the Implant Experience, Transponder Stability and Tracking Data of the Calypso 4D Localization Study in the Prostate Bed
Status: Enrolling
Updated: 10/13/2015
Metropolitan Uro-Rad
mi
from
St. Louis, MO
Click here to add this to my saved trials
Cabozantinib (XL184) in Men With Castrate-Resistant Prostate Cancer
Dose-Finding Pilot Study of XL184 in Men With Castrate-Resistant Prostate Cancer and Bone Metastases
Status: Enrolling
Updated:  10/16/2015
Massachusetts General Hospital
mi
from
Boston, MA
Cabozantinib (XL184) in Men With Castrate-Resistant Prostate Cancer
Dose-Finding Pilot Study of XL184 in Men With Castrate-Resistant Prostate Cancer and Bone Metastases
Status: Enrolling
Updated: 10/16/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Prostate Biomarker Study
Multi-Institutional Inter-SPORE Prostate Biomarker Study
Status: Enrolling
Updated:  10/18/2015
UCLA
mi
from
Los Angeles, CA
Prostate Biomarker Study
Multi-Institutional Inter-SPORE Prostate Biomarker Study
Status: Enrolling
Updated: 10/18/2015
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prostate Biomarker Study
Multi-Institutional Inter-SPORE Prostate Biomarker Study
Status: Enrolling
Updated:  10/18/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Prostate Biomarker Study
Multi-Institutional Inter-SPORE Prostate Biomarker Study
Status: Enrolling
Updated: 10/18/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older
Phase II Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older
Status: Enrolling
Updated:  10/19/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older
Phase II Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older
Status: Enrolling
Updated: 10/19/2015
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Exercise for Physical Health in Men With Prostate Cancer
Exercise for Physical Health in Men With Prostate Cancer
Status: Enrolling
Updated:  10/20/2015
OHSU School of Nursing
mi
from
Portland, OR
Exercise for Physical Health in Men With Prostate Cancer
Exercise for Physical Health in Men With Prostate Cancer
Status: Enrolling
Updated: 10/20/2015
OHSU School of Nursing
mi
from
Portland, OR
Click here to add this to my saved trials
BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets
A Limited, First-in-Man, Phase IB Evaluation of BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With High-Volume Osseous Metastases and no Standard Treatment Options
Status: Enrolling
Updated:  10/22/2015
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets
A Limited, First-in-Man, Phase IB Evaluation of BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With High-Volume Osseous Metastases and no Standard Treatment Options
Status: Enrolling
Updated: 10/22/2015
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
A Randomized, Double-blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination With OGX-427 or Placebo in Patients With Advanced Transitional Cell Carcinoma
Status: Enrolling
Updated:  10/22/2015
City of Hope National Medical Center
mi
from
Duarte, CA
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
A Randomized, Double-blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination With OGX-427 or Placebo in Patients With Advanced Transitional Cell Carcinoma
Status: Enrolling
Updated: 10/22/2015
City of Hope National Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
A Randomized, Double-blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination With OGX-427 or Placebo in Patients With Advanced Transitional Cell Carcinoma
Status: Enrolling
Updated:  10/22/2015
University of California at Los Angeles
mi
from
Los Angeles, CA
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
A Randomized, Double-blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination With OGX-427 or Placebo in Patients With Advanced Transitional Cell Carcinoma
Status: Enrolling
Updated: 10/22/2015
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
A Randomized, Double-blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination With OGX-427 or Placebo in Patients With Advanced Transitional Cell Carcinoma
Status: Enrolling
Updated:  10/22/2015
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
A Randomized, Double-blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination With OGX-427 or Placebo in Patients With Advanced Transitional Cell Carcinoma
Status: Enrolling
Updated: 10/22/2015
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
A Randomized, Double-blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination With OGX-427 or Placebo in Patients With Advanced Transitional Cell Carcinoma
Status: Enrolling
Updated:  10/22/2015
Radiological Associates of Sacramento
mi
from
Sacramento, CA
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
A Randomized, Double-blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination With OGX-427 or Placebo in Patients With Advanced Transitional Cell Carcinoma
Status: Enrolling
Updated: 10/22/2015
Radiological Associates of Sacramento
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
A Randomized, Double-blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination With OGX-427 or Placebo in Patients With Advanced Transitional Cell Carcinoma
Status: Enrolling
Updated:  10/22/2015
Yale University
mi
from
New Haven, CT
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
A Randomized, Double-blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination With OGX-427 or Placebo in Patients With Advanced Transitional Cell Carcinoma
Status: Enrolling
Updated: 10/22/2015
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
A Randomized, Double-blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination With OGX-427 or Placebo in Patients With Advanced Transitional Cell Carcinoma
Status: Enrolling
Updated:  10/22/2015
Siteman Cancer Center, Washington University School of Medicine
mi
from
St. Louis, MO
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
A Randomized, Double-blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination With OGX-427 or Placebo in Patients With Advanced Transitional Cell Carcinoma
Status: Enrolling
Updated: 10/22/2015
Siteman Cancer Center, Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
A Randomized, Double-blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination With OGX-427 or Placebo in Patients With Advanced Transitional Cell Carcinoma
Status: Enrolling
Updated:  10/22/2015
Urology Cancer Center & GU Research Network
mi
from
Omaha, NE
A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer
A Randomized, Double-blind Phase 2 Study Comparing Gemcitabine and Cisplatin in Combination With OGX-427 or Placebo in Patients With Advanced Transitional Cell Carcinoma
Status: Enrolling
Updated: 10/22/2015
Urology Cancer Center & GU Research Network
mi
from
Omaha, NE
Click here to add this to my saved trials